Median Technologies Profile Banner
Median Technologies Profile
Median Technologies

@MEDIANTechno

960
Followers
198
Following
660
Media
1,590
Statuses

Median harnesses the power of medical images by using AI to bring earlier diagnosis and new treatments to oncology patients.

Europe - USA - China
Joined February 2012
Don't wanna be here? Send us removal request.
@MEDIANTechno
Median Technologies
3 years
We are pleased to announce that in 2021 #mediantechnologies ’ business continued to grow at a rapid pace. Check out our press release -> #AIforhealth #ibiopsy #lungcancerscreening #oncology #clinicaltrials #iCRO
Tweet media one
4
16
53
@MEDIANTechno
Median Technologies
3 years
#mediantechnologies announces outstanding lung nodules detection performance for #ibiopsy Lung Cancer Screening. Performance reaches 94.9% sensitivity for a false positive rate of 1 per CT scan👉
Tweet media one
0
14
49
@MEDIANTechno
Median Technologies
3 years
Live from Chicago! At #RSNA21 - Yan Liu, Chief Medical Officer and @Benoit_Huet , director #AI and #datascience #ibiopsy presenting our latest #lungcancerscreening results at the #aitheater
Tweet media one
0
12
47
@MEDIANTechno
Median Technologies
3 years
@mediantechno announces new outstanding performance for its iBiopsy Lung Cancer Screening CADx with a focus on stage 1 lung cancer characterization @BragFredrik #AIforhealth #ibiopsy #mediantechnologies #almdt #lungcancer
Tweet media one
0
14
40
@MEDIANTechno
Median Technologies
3 years
#mediantechnologies announces outstanding performance for #ibiopsy Lung Cancer Screening CADx. #aiforhealth #imagingbiomarker #lungcancerscreening Our full press release ->
Tweet media one
3
7
37
@MEDIANTechno
Median Technologies
3 years
Dans les coulisses de la préparation du #RSNA21 . Prêt bientôt et heureux de vous accueillir à partir de dimanche 28 novembre 10 heures, stand 4849, level 3, south hall, AI showcase #ibiopsy #aiforhealth #chicago #mccormick
Tweet media one
0
7
36
@MEDIANTechno
Median Technologies
22 days
Super proud and happy to announce that our eyonis™ LCS, our medical device for lung cancer screening , met the primary and all secondary endpoints in REALITY, the first of two pivotal studies required for marketing authorizations in U.S. and Europe:
Tweet media one
8
9
32
@MEDIANTechno
Median Technologies
3 years
#almdt #mediantechnologies files FDA 513(g) regulatory submission for iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device - check out our press release: #ibiopsy #lungcancer #lungcancerscreening
Tweet media one
0
13
31
@MEDIANTechno
Median Technologies
3 years
On Nov. 28th at 12pm CT, our #MedianTechnologies experts will present on “iBiopsy® AI-powered Lung Cancer Screening” at the #RSNA21 AI Showcase Theater. Happy to see you there and at our booth #4849 . Want to schedule a meeting with the team? -> #lungcancer
Tweet media one
0
10
30
@MEDIANTechno
Median Technologies
3 years
With a 71% increase in half-year revenue to €10.1m from €5.9m in H1 2020, #mediantechnologies business continues to grow at a steady pace in the first half of 2021- read our press release👉 #icro #ibiopsy #aiforhealth #medicalimaging #oncology
Tweet media one
0
10
28
@MEDIANTechno
Median Technologies
3 years
Our latest corporate update is now online: check our website investor section for more details 👉 #MedianTechnologies #iCRO #iBiopsy
Tweet media one
0
9
25
@MEDIANTechno
Median Technologies
3 years
We are pleased to announce a new scientific paper: “Emerging technologies and their impact on regulatory science”, led by the U.S. FDA. Dr. Yan Liu, CMO at #MedianTechnologies was selected to participate in the elaboration of this paper! Want to know more?
Tweet media one
3
11
26
@MEDIANTechno
Median Technologies
3 years
⌚️⌚️⏳Notre webcast, c'est à 18h aujourdhui et pour se connecter, c'est ici 👉
Tweet media one
4
5
24
@MEDIANTechno
Median Technologies
3 years
Fredrik Brag, CEO et fondateur, commende l’actualité de rentrée de Median sur le plateau de @Boursorama -> c’est ici :
Tweet media one
0
7
23
@MEDIANTechno
Median Technologies
3 years
#iBiopsy #lungcancerscreening CADe/CADx SaMD positions itself to dramatically increase the efficacy of lung cancer screening programs worldwide, which would facilitate saving the lives of millions. #AIforhealth #almdt #mediantechnologies @BragFredrik
Tweet media one
0
5
23
@MEDIANTechno
Median Technologies
4 years
We released today our first results on AI-based non-invasive biomarkers for #NASH patients! first results indicate that AI could help identify the severity of the disease in NASH patients -> want to know more: #ibiopsy #AIforhealth #imaging #biomarker
Tweet media one
0
8
23
@MEDIANTechno
Median Technologies
4 years
Press Release: #MedianTechnologies continues its strong positioning in early-stage diagnosis with a new iBiopsy® Clinical Development Plan on Lung Cancer Screening (LCS) -> #lungcancer #imaging #biomarker #ibiopsy #diagnostic #AIforhealth
Tweet media one
0
5
22
@MEDIANTechno
Median Technologies
4 years
Thrilled to announce our research collaboration agreement with UC San Diego. The development of a noninvasive biomarker to diagnose early NASH is critical for patients! Read more @UCSDMedSchool #liverdisease #Nash #AIforhealth #MedianTechnologies #ibiopsy
Tweet media one
0
9
20
@MEDIANTechno
Median Technologies
3 years
On Nov. 23, our experts will discuss modern imaging biomarker covering the most important cancer hallmarks and how they could be used in oncology trials for early response assessment and disease management. Save your spot now: @LabcorpDrugDev @APHP
Tweet media one
0
4
21
@MEDIANTechno
Median Technologies
3 years
"Median se projette en très grand". L'intégralité de l'article #mediantechnologies paru dans la newsletter @Biotech_finance du 12 Avril disponible (merci BiotechFinances 🙂). Le lien: - English translation soon... #AIforhealth #ibiopsy #imagingbiomarkers
Tweet media one
0
9
21
@MEDIANTechno
Median Technologies
4 months
💫Proud to announce that our company has been selected as a preferred clinical trial imaging services provider for another leading global pharmaceutical company. We are now preferred provider for two of the Top 3 global pharma companies!
Tweet media one
0
2
20
@MEDIANTechno
Median Technologies
3 years
Le 4 février est la #Journeemondialecontrelecancer . Les technologies médicales avancées peuvent aider à offrir plus d’équité dans le diagnostic et le traitement des cancers. Nous, #MedianTechnologies , sommes fiers de contribuer à vaincre le #cancer avec iCRO et iBiopsy®.
Tweet media one
0
4
20
@MEDIANTechno
Median Technologies
4 years
Heureux d’avoir accueilli un large public à notre webcast hier, pour un point sur notre actualité et nos perspectives. Merci aux participants pour leurs questions😊. L’enregistrement du webcast est ici :
Tweet media one
0
6
20
@MEDIANTechno
Median Technologies
2 years
New and breakthrough results for our iBiopsy LCS CADe/CADx SaMD showing a considerable increase of our proprietary algorithms performance with a sensitivity of 96.5% for a specificity of 97.2% -> our PR on:
Tweet media one
1
5
19
@MEDIANTechno
Median Technologies
3 years
Median is a proud sponsor of the #QIW2021 ! Early diagnosis of #lungcancer can save lives: we develop #ibiopsy a unique AI-powered end-to-end CADe/CADx SaMD that integrates & optimizes the entire medical imaging workflow in lung cancer detection. More info:
Tweet media one
1
5
19
@MEDIANTechno
Median Technologies
2 years
We released today our business indicators for the first half of the year. Our company continued its strong growth with Q2, 2022 revenues of €7 million, a 43% increase versus Q2, 2021. Read our press release👉👉
Tweet media one
1
3
19
@MEDIANTechno
Median Technologies
3 years
Nicolas Dano, COO #iCRO Business Unit at #MedianTechnologies , is attending the ARENA Outsourcing in Clinical Trials conference today and tomorrow in Copenhagen. Connect with Nicolas to learn more about our imaging services for oncology trials. More info:
Tweet media one
0
5
19
@MEDIANTechno
Median Technologies
3 years
Our team in China has grown considerably in 2021 and wishes you a happy #holidayseason ! ❄️ Take care and see you in 2022 😊 #MedianTechnologies
Tweet media one
5
3
19
@MEDIANTechno
Median Technologies
3 years
Dans les coulisses de notre webcast ! Nous sommes très nombreux en ligne mais n’hésitez pas à poser vos questions via le chat du webcast ! La session de questions / réponses arrive ! #mediantechnologies #ibiopsy #imagingbiomarkers #oncology #clinicaltrials
Tweet media one
4
2
19
@MEDIANTechno
Median Technologies
4 years
Tweet media one
1
6
18
@MEDIANTechno
Median Technologies
4 years
Thema Radiologie : Un biomarqueur non invasif de la fibrose hépatique à partir d’images tomodensitométriques devrait permettre d’éviter la biopsie pour évaluer le degré de récidive du CHC. C’est ce que montre une étude lancée par Median Technologies.
Tweet media one
0
6
18
@MEDIANTechno
Median Technologies
3 years
#MedianWebinar : on Feb. 1st, our #MedianTechnologies experts will address the 4 main causes of variability occurring during RECIST1.1 assessment and describe control strategies using data analytics and medical investigations. Register now: #oncology
Tweet media one
0
3
18
@MEDIANTechno
Median Technologies
8 months
In an important milestone towards market introduction, Median's CADe/CADx SaMD eyonis LCS has demonstrated excellent performance in an independent verification study—a critical step in the regulatory process for obtaining 510(k) clearance & CE marking👉
Tweet media one
7
4
9
@MEDIANTechno
Median Technologies
3 years
Watch our new video now to learn more about iBiopsy®, our unique end-to-end #AI -powered SaMD that supports radiologists and clinicians in the screening, early diagnosis and treatment of #oncology and metabolic diseases 👉 #iBiopsy #MedianTechnologies
Tweet media one
0
5
18
@MEDIANTechno
Median Technologies
4 years
Initiation de la couverture de Median Technologies par Gilbert Dupont - "L’imagerie, levier du diagnostic médical". Etude publiée le 8/09/2020 #investors #analysefinanciere #analystcoverage #SmallCaps
Tweet media one
0
10
17
@MEDIANTechno
Median Technologies
3 years
Avant-hier, @Benoit_Huet , Artificial Intelligence & Data Science Director iBiopsy® chez #MedianTechnologies a présenté les développements de iBiopsy® dans le domaine du dépistage du cancer du poumon, lors de l’événement organisé par le @PoleEurobiomed au @CHUdeNice . #AI #iBiopsy
Tweet media one
0
5
17
@MEDIANTechno
Median Technologies
3 years
#iCRO will be attending the Outsourcing in Clinical Trials New England conference in Boston MA tomorrow, Nov.9 until Nov.10. If you want to learn more about our imaging services, meet us in Boston! More info👉 #mediantechnologies #medicalimaging
Tweet media one
0
2
17
@MEDIANTechno
Median Technologies
3 years
Today is #WorldCancerDay . Developing advanced medical technologies can help close the gap in #cancer care by giving everyone equal access to cancer diagnosis and treatment. At #MedianTechnologies we are committed to helping conquer cancer with iCRO and iBiopsy®. #CloseTheCareGap
Tweet media one
1
2
17
@MEDIANTechno
Median Technologies
3 years
As an imaging CRO, #MedianTechnologies uses a high level of automation at different stages of the imaging workflow to improve data consistency/value, and streamline study workflow. Want to know more about the Median solution? Click here: #iCRO
Tweet media one
0
4
17
@MEDIANTechno
Median Technologies
3 years
Our latest corporate update presentation is now available on our website: Contact us: Our #MedianTechnologies team will be pleased to answer your requests! #medicalimaging #iBiopsy #iCRO
Tweet media one
1
5
16
@MEDIANTechno
Median Technologies
2 years
Fiers d'avoir reçu le prix #entreprenariales2022 #innovation #intelligenceartificielle décerné par @Tribuca & remis par @JpSavarino @CCIcotedazur à Fredrik Brag, CEO. Merci aux partenaires @UPE_06 @PierreIppolito @francebleuazur - @IsabelleAuzias . merci aux équipes de Median 🙏👏
Tweet media one
1
4
16
@MEDIANTechno
Median Technologies
3 years
#iCRO will be attending the Immuno-Oncology 360° conference on March 16-18 in New York. If you want to learn more about our imaging services for #oncology trials, meet us in New-York! If you need more info, contact us: #IO360nyc @ConferenceForum
Tweet media one
0
2
16
@MEDIANTechno
Median Technologies
3 years
#iCRO will be attending the Outsourcing in Clinical Trials conference on Dec. 8-9 in London. If you want to learn more about our imaging services for #oncology trials, meet us in London! If you need more info, contact us: @ArenaIntCTS #MedianTechnologies
Tweet media one
0
3
16
@MEDIANTechno
Median Technologies
3 years
#MedianTechnologies will participate in the #RSNA21 annual meeting! We will be presenting the latest advances in iBiopsy®, our unique AI-powered technology Software as a Medical Device (SaMD). Meet the team at booth #4849 . Schedule a meeting with us:
Tweet media one
0
6
16
@MEDIANTechno
Median Technologies
4 years
Despite the Covid crisis, 2020 was a very productive year for Median and a record year for our iCRO activity! Read our press release: 👉 #AI #mediantechnologies #icro #clinicaltrials #medicalimaging
Tweet media one
0
9
15
@MEDIANTechno
Median Technologies
3 years
Median Technologies has been confirmed as a preferred vendor by one of the Top 3 pharmaceutical companies in the world, and selected to implement their clinical trial imaging strategy on some key oncology indications -> our press release:
Tweet media one
0
6
16
@MEDIANTechno
Median Technologies
3 years
In the U.S., February is the #NationalCancerPreventionMonth . #Lungcancer is the most commonly diagnosed cancer and the leading cause of cancer death in the world, with over 2.2 million new cases in 2020 and nearly 1.8 million deaths (Global Cancer Observatory, Dec. 2020) #iBiopsy
Tweet media one
1
4
16
@MEDIANTechno
Median Technologies
3 years
We are pleased to announce a new scientific paper published in Cancers Journal “Blinded Independent Central Review (BICR) in New Therapeutic Lung Cancer Trials”. Want to know more about this work --> #mediantechnologies #medicalimaging
Tweet media one
0
4
15
@MEDIANTechno
Median Technologies
3 years
#MedianTechnologies reports on its 2021 half-year results and its Q3 2021 business activity indicators - read our full press release here👉 #ibiopsy #AIforhealth #imagingbiomarkers #lungcancer #lungcancerscreening #oncology #clinicaltrials #medicalimaging
Tweet media one
0
3
15
@MEDIANTechno
Median Technologies
2 years
We announced today completion of the Q-submission phase with the FDA for our iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device and are proud to announce that iBiopsy® LCS CADe/CADx SaMD pivotal study protocols are now finalized ->
0
2
15
@MEDIANTechno
Median Technologies
4 years
Promising results of a first retrospective study on the implementation of #ibiopsy for the analysis of patients with solid tumor cancers who are likely to be responsive to immuno-oncology treatments. Read more: #MedianTechnologies #AIforhealth #biomarkers
Tweet media one
1
10
15
@MEDIANTechno
Median Technologies
3 years
⏰ Rendez-vous demain 15 Février à 19h pour la web conference organisée par @Biotech_finance avec Jacques-Bernard Taste qui recevra @BragFredrik pour parler de l’actualité en imagerie médicale! Webconf ouverte à tous ici 📎👉👉
0
6
15
@MEDIANTechno
Median Technologies
3 years
Voyage sonore dans les locaux de #mediantechnologies avec @BragFredrik le temps d'un podcast de la série D'utilité Publique de la @caissedesdepots et #CDCCroissance 🎤🎧 #startups #Aiforhealth
1
5
15
@MEDIANTechno
Median Technologies
3 years
2021 was an incredible year for Median: 80+ persons joined the Median team in China, France and in the US! In 2022, our #iCRO , #iBiopsy and Corporate teams are still growing and looking for talents! If you want to join us, find your dream job here 👉
Tweet media one
0
2
15
@MEDIANTechno
Median Technologies
4 years
#mediantechnologies H1 2020 results: Strong revenue growth, accelerated investments and initial promising results for #iBiopsy . Read our press release 👉 #icro #clinicaltrials #imaging #AIforhealth #aiforgood #sophiaantipolis @risingSUD
Tweet media one
1
11
15
@MEDIANTechno
Median Technologies
3 years
#iCRO will be attending the Outsourcing in Clinical Trials conference on Dec. 7-8 in San Diego, CA. If you want to learn more about our imaging services, meet us in San Diego! If you need more info, contact us: @ArenaIntCTS #MedianTechnologies
Tweet media one
0
3
15
@MEDIANTechno
Median Technologies
10 months
A momentous occasion today for #Median with the privilege of being received at the Élysée by the French President. Proud to be part of the French companies chosen in 2023 by the Minister of Economy and Finance to participate in the ETIncelles program. #Economie_Gouv
Tweet media one
3
2
15
@MEDIANTechno
Median Technologies
2 months
#WorldLungCancerDay has been observed every year since August 1st, 2012; as Lung cancer remains among the most prevalent cancers globally. #Median is investing in an end-to-end #AI / #ML tech-based #CADe / #CADx #SaMD to support radiologists in #earlylungcancer diagnosis. #eyonis
1
4
14
@MEDIANTechno
Median Technologies
3 years
Heureux d’avoir accueilli un large public à notre webcast lundi, pour un point sur notre actualité et nos perspectives. Merci aux participants pour leurs questions😊. L’enregistrement du webcast est ici : #MedianTechnologies
Tweet media one
2
3
14
@MEDIANTechno
Median Technologies
3 years
#MedianTechnologies is a member of the Chinese Society of Clinical Oncology and will be virtually participating in the 24th CSCO annual conference from September 25-29! Meet us online: #oncology #iCRO #clinicaltrials
Tweet media one
0
1
14
@MEDIANTechno
Median Technologies
2 years
October is #LiverCancerAwarenessMonth . HCC is a health problem and is considered one of the leading causes of cancer-related deaths worldwide (1). More than 800,000 people died from liver cancer in 2020, making liver cancer the 3rd most common cause of cancer death globally (2).
Tweet media one
0
7
14
@MEDIANTechno
Median Technologies
3 years
To all our clients, partners, and patients who suffer from #cancer and other life-threatening diseases: we at #MedianTechnologies , wish you and your loved ones a wonderful holiday season and all the best for 2022.🎄 #holidayseason
1
2
13
@MEDIANTechno
Median Technologies
3 years
Our first #MedianWebinar of 2022 is coming soon! In the meantime you can still watch the video of our latest joint webinar with @LabcorpDrugDev : "Imaging in oncology trials: can it help to make go or no go decisions?". The video is available here:
Tweet media one
1
1
13
@MEDIANTechno
Median Technologies
3 years
After 1 year of virtual events, we will be so pleased to see you in person during the annual meeting of the #RSNA21 from November 28 to December 2 in Chicago, IL, USA. Come and see us at booth # 4849 South Hall A Level 3! We will be presenting the latest advances in iBiopsy®.
Tweet media one
1
2
14
@MEDIANTechno
Median Technologies
3 years
November is #LungCancerAwarenessMonth . At #MedianTechnologies , we are committed to supporting this cause and we are developing #iBiopsy , a unique AI-powered end-to-end CADe/CADx SaMD that integrates & optimizes the entire medical imaging workflow in lung cancer detection.
Tweet media one
0
4
14
@MEDIANTechno
Median Technologies
4 years
New scientific paper published in European Radiology “Harmonization of radiomic feature distributions: impact on classification of hepatic tissue in CT imaging”. Want to know more about this work -> #mediantechnologies #MedicalImaging
Tweet media one
0
2
14
@MEDIANTechno
Median Technologies
2 years
@MEDIANTechno reports full-year 2021 results and business indicators for the first quarter of 2022 -> our press release is here 👉👉
Tweet media one
0
0
14
@MEDIANTechno
Median Technologies
3 years
2020 results in line with expectations and very strong growth of Median's business activity indicators in Q1, 2021 #mediantechnologies #ibiopsy #imagingbiomarkers #sophiaantipolis - Read our press release 👉
Tweet media one
1
3
14
@MEDIANTechno
Median Technologies
2 years
@BragFredrik , CEO et fondateur, commente l’actualité de Median Technologies sur le plateau de @Boursorama et répond aux questions de @Laurent_Grassin : les dernières annonces concernant #iBiopsy pour le dépistage du cancer du poumon. Cliquez ici 👉
Tweet media one
0
4
13
@MEDIANTechno
Median Technologies
4 years
Median Technologies en marche pour révolutionner la médecine | Bpifrance servir l'avenir ⁦ @Bpifrance
0
7
12
@MEDIANTechno
Median Technologies
3 years
#iCRO will be attending the Outsourcing in Clinical Trials conference on Nov. 24-25 in Zurich, Switzerland. If you want to learn more about our imaging services, meet us in Zurich! More info 👉 @ArenaIntCTS #MedianTechnologies #clinicaltrials
Tweet media one
0
4
13
@MEDIANTechno
Median Technologies
3 years
#mediantechnologies sur le haut du podium des levées de fond sur la Côte d’Azur en 2021 ! 😁 on est médaille d’or 🥇donc 😁😁. Fiers de participer à l’écosystème de la santé et de contribuer à un monde en meilleure santé ! …
@InvestCotedAzur
Invest in Côte d'Azur
3 years
📈Chiffre de la semaine : 130.65 Millions d'Euros C'est le montant total des #lev éesdefonds annoncées en 2021 par 19 entreprises présentes sur la Côte d'Azur. ➕ #investincotedazur #succeedincotedazur
0
0
2
0
5
13
@MEDIANTechno
Median Technologies
2 years
@mediantechno is moving forward with the FDA interactions for its #iBiopsy #Lungcancerscreening CADe/CADx Software as Medical Device #AI #AIforhealth #lungcancer #screening Our press release is here: $ALMDT #ALMDT
Tweet media one
0
2
12
@MEDIANTechno
Median Technologies
3 years
🕙⏳Plus que 4 jours pour vous inscrire à notre prochain webcast (en français) : lundi 25 Octobre à 18h, Fredrik Brag, CEO et fondateur de #MedianTechnologies , présentera l'actualité de la société et répondra aux questions des participants. Inscription 👉
Tweet media one
0
3
12
@MEDIANTechno
Median Technologies
4 years
Our latest scientific poster presented at the AASLD Liver meeting that took place from Nov 13-16, is now online here: #mediantechnologies #ibiopsy #liverdisease #radiomics #AIforhealth
Tweet media one
0
3
12
@MEDIANTechno
Median Technologies
3 years
1 day left to join our #webinar “Imaging in oncology trials: can it help to make go or no go decisions?” co-organized with @LabcorpDrugDev . Have you saved your spot yet? Register now: #MedianTechnologies #oncology
Tweet media one
0
1
12
@MEDIANTechno
Median Technologies
3 years
[Did you know?] Historically, in radiology practice, trained physicians visually assessed medical images for the detection, characterization and monitoring of diseases. #AI algorithms, particularly #DeepLearning , have demonstrated remarkable progress in image-recognition tasks.
Tweet media one
0
8
12
@MEDIANTechno
Median Technologies
3 years
Did you miss our joint webinar with @LabcorpDrugDev ? Not everything is lost! You can still watch our webinar video “Imaging in oncology trials: can it help to make go or no go decisions?” here: #MedianTechnologies #oncology #webinar
Tweet media one
0
3
12
@MEDIANTechno
Median Technologies
11 months
First results of #iBiopsy ® HCC detection #AI model will be presented at the #ESMO23 . Results show 92% HCC lesion detection sensitivity of iBiopsy®, vs. a sensitivity of 69% (radiologists without AI-based computer-aided detection) >>
Tweet media one
3
4
12
@MEDIANTechno
Median Technologies
2 years
AI-powered medical imaging helps improve patient outcomes. Median Technologies is at the forefront of this advanced imaging evolution, transforming clinical trial images into intelligent insights for pharma customers worldwide. Read the article here:
0
2
12
@MEDIANTechno
Median Technologies
4 years
⏰Fredrik Brag, CEO #mediantechnologies demain à la table ronde organisée par @PoleEurobiomed et animée par Jacques Bernard Taste @Biotech_finance . Au programme, les impacts de la crise sanitaire de la Covid 19 sur la filière Santé. Plus d'infos 👉
1
3
12
@MEDIANTechno
Median Technologies
4 years
Great to announce that Dr. Yan Liu, CMO of #MedianTechnologies is part of the #ChoiseulRegionSud 2020 ranking. The ranking selects young industry leaders who contribute to the economic influence of the Region Sud. @Nice_Matin @laprovence @instchoiseul #sophiaantipolis
Tweet media one
0
5
11
@MEDIANTechno
Median Technologies
3 years
#ASCO21 Virtual Meeting - Our abstract “Machine learning based biomarkers to predict CD8 infiltration in non-small cell lung cancers using CT imaging” is now online:
Tweet media one
0
8
12
@MEDIANTechno
Median Technologies
3 years
Tweet media one
0
4
11
@MEDIANTechno
Median Technologies
4 years
our recent announcement about the use of our proprietary #ibiopsy #ai technology for the evaluation of #liver #fibrosis severity in #nash patients: non invasive #imagingbiomarkers make the difference! #mediantechnologies #aiforhealth
0
6
11
@MEDIANTechno
Median Technologies
3 years
#MedianTechnologies is a proud sponsor of the Young Big Young Scientist Forum. On Nov.12 at 4:30pm (GMT+8), a debate session will take place and Zhang Min (Robin), General Manager #iCRO at Median China will make a speech after the debate then give the prize to the debate winners.
Tweet media one
0
5
11
@MEDIANTechno
Median Technologies
4 years
Dans les coulisses de notre présentation investisseurs professionnels à Paris aujourd’hui - le slideshow de notre présentation en ligne sur notre site à 14h - rubrique investisseurs @ActifinNews @usquareparis #mediantechnologies #ibiopsy #aiforhealth #icro #imagingbiomarkers
Tweet media one
0
6
11
@MEDIANTechno
Median Technologies
2 years
#RSNA2022 just opening today with a presentation of #iBiopsy LCS AI/ML tech-based CADe/CADx Software as Medical Device. A great opportunity to share our results with the #radiology community! thank you Yan Liu, CMO and @Benoit_Huet for presenting #lungcancer #screening
Tweet media one
1
1
11
@MEDIANTechno
Median Technologies
3 years
Join us on November 23 to participate in our first joint webinar with @LabcorpDrugDev ! Our experts from #MedianTechnologies , @LabcorpDrugDev and @APHP will present “Imaging in Oncology trials: can it help to make “go or no go” decisions?”. Register now:
Tweet media one
0
4
11
@MEDIANTechno
Median Technologies
3 years
Zhang Min (Robin) General Manager iCRO at Median China will be presenting on Regulatory Considerations on Imaging Endpoint Procedures in Oncology Trials: a Comparison of China NMPA and FDA Guidelines on Oct.15 at 2:35pm (GMT+8) during the China Taihu Biomed Innovation Conference.
Tweet media one
0
2
11
@MEDIANTechno
Median Technologies
4 years
Dr. Yan Liu, CMO at Median to present at the virtual #GSRS2020 on Emerging Technologies and Their Application to Regulatory Science. Her presentation: Next generation #AI based imaging #biomarkers for #PrecisionMedicine -> #FDA #AIforhealth #ibiopsy
Tweet media one
0
4
11
@MEDIANTechno
Median Technologies
3 years
October is coming to an end but the fight against #breastcancer continues! At #MedianTechnologies , putting the patient first is one of our core values, a big thank you to our employees who are committed to supporting this cause and wear the Pink October colors very nicely😊
Tweet media one
0
2
11
@MEDIANTechno
Median Technologies
4 years
Tweet media one
0
5
10
@MEDIANTechno
Median Technologies
3 years
Do you know what are the 4 main causes of variability occurring during RECIST 1.1 assessment? Join our #MedianTechnologies experts on Feb. 1st to learn more. Register here: #MedianWebinar #oncology #clinicaltrials
Tweet media one
0
2
10
@MEDIANTechno
Median Technologies
3 years
Le webcast de notre assemblée générale mixte du 1er Juin 2021 qui s'est tenue à huit clos conformément à la règlementation en vigueur actuellement, est désormais en ligne sur notre chaîne Youtube !
Tweet media one
1
6
10
@MEDIANTechno
Median Technologies
1 year
With #iBiopsy , our end-to-end #AI / #ML tech-based CADe/CADx SaMD, we focus to further improve the support of physicians in the early diagnosis of #LungCancer and #LiverCancer and reduce the burden for patients’ lives.
0
4
10
@MEDIANTechno
Median Technologies
2 years
Last Friday at @WAICANNES , Rémi Ronchaud, Program Management & Operational Excellence Director iBiopsy® at #MedianTechnologies , presented during a panel on the #AI ecosystem in Sophia Antipolis. We are pleased and proud to be part of the AI landscape in Sophia! #waicf
Tweet media one
1
3
10